These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22809586)
1. The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy. Tsang Y; Haviland J; Venables K; Yarnold J; Radiother Oncol; 2012 Aug; 104(2):143-7. PubMed ID: 22809586 [TBL] [Abstract][Full Text] [Related]
2. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. ; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR Lancet Oncol; 2008 Apr; 9(4):331-41. PubMed ID: 18356109 [TBL] [Abstract][Full Text] [Related]
3. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT. Brunt AM; Haviland JS; Wheatley DA; Sydenham MA; Bloomfield DJ; Chan C; Cleator S; Coles CE; Donovan E; Fleming H; Glynn D; Goodman A; Griffin S; Hopwood P; Kirby AM; Kirwan CC; Nabi Z; Patel J; Sawyer E; Somaiah N; Syndikus I; Venables K; Yarnold JR; Bliss JM; Health Technol Assess; 2023 Nov; 27(25):1-176. PubMed ID: 37991196 [TBL] [Abstract][Full Text] [Related]
4. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Haviland JS; Owen JR; Dewar JA; Agrawal RK; Barrett J; Barrett-Lee PJ; Dobbs HJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Simmons S; Sydenham MA; Venables K; Bliss JM; Yarnold JR; Lancet Oncol; 2013 Oct; 14(11):1086-1094. PubMed ID: 24055415 [TBL] [Abstract][Full Text] [Related]
5. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Murray Brunt A; Haviland JS; Wheatley DA; Sydenham MA; Alhasso A; Bloomfield DJ; Chan C; Churn M; Cleator S; Coles CE; Goodman A; Harnett A; Hopwood P; Kirby AM; Kirwan CC; Morris C; Nabi Z; Sawyer E; Somaiah N; Stones L; Syndikus I; Bliss JM; Yarnold JR; Lancet; 2020 May; 395(10237):1613-1626. PubMed ID: 32580883 [TBL] [Abstract][Full Text] [Related]
6. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Coles CE; Griffin CL; Kirby AM; Titley J; Agrawal RK; Alhasso A; Bhattacharya IS; Brunt AM; Ciurlionis L; Chan C; Donovan EM; Emson MA; Harnett AN; Haviland JS; Hopwood P; Jefford ML; Kaggwa R; Sawyer EJ; Syndikus I; Tsang YM; Wheatley DA; Wilcox M; Yarnold JR; Bliss JM; Lancet; 2017 Sep; 390(10099):1048-1060. PubMed ID: 28779963 [TBL] [Abstract][Full Text] [Related]
7. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. ; Bentzen SM; Agrawal RK; Aird EG; Barrett JM; Barrett-Lee PJ; Bentzen SM; Bliss JM; Brown J; Dewar JA; Dobbs HJ; Haviland JS; Hoskin PJ; Hopwood P; Lawton PA; Magee BJ; Mills J; Morgan DA; Owen JR; Simmons S; Sumo G; Sydenham MA; Venables K; Yarnold JR Lancet; 2008 Mar; 371(9618):1098-107. PubMed ID: 18355913 [TBL] [Abstract][Full Text] [Related]
8. Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Nozaki M; Kagami Y; Machida R; Nakamura K; Ito Y; Nishimura Y; Teshima T; Saito Y; Nagata Y; Matsumoto Y; Akimoto T; Hiraoka M; Jpn J Clin Oncol; 2021 May; 51(6):865-872. PubMed ID: 33728450 [TBL] [Abstract][Full Text] [Related]
9. Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation. Haviland JS; Bentzen SM; Bliss JM; Yarnold JR; Radiother Oncol; 2016 Dec; 121(3):420-423. PubMed ID: 27666929 [TBL] [Abstract][Full Text] [Related]
10. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH; Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696 [TBL] [Abstract][Full Text] [Related]
11. Ten-year results of accelerated hypofractionated adjuvant whole-breast radiation with concomitant boost to the lumpectomy cavity after conserving surgery for early breast cancer. Cante D; Petrucci E; Sciacero P; Piva C; Ferrario S; Bagnera S; Patania S; Mondini G; Pasquino M; Casanova Borca V; Vellani G; La Porta MR; Franco P Med Oncol; 2017 Sep; 34(9):152. PubMed ID: 28776318 [TBL] [Abstract][Full Text] [Related]
12. Hypofractionation in the era of modulated radiotherapy (RT). Mouw KW; Harris JR Breast; 2013 Aug; 22 Suppl 2():S129-36. PubMed ID: 24074773 [TBL] [Abstract][Full Text] [Related]
14. Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence. Bantema-Joppe EJ; Vredeveld EJ; de Bock GH; Busz DM; Woltman-van Iersel M; Dolsma WV; van der Laan HP; Langendijk JA; Maduro JH Radiother Oncol; 2013 Aug; 108(2):269-72. PubMed ID: 24055289 [TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes of Post-mastectomy Breast Cancer Patients Treated with Hypofractionated Radiation Treatment Compared to Conventional Fractionation -a Retrospective Cohort Study. Raveendran C; Meloot SS; Yadev I Gulf J Oncolog; 2023 May; 1(42):26-34. PubMed ID: 37283257 [TBL] [Abstract][Full Text] [Related]
16. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy. Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271 [TBL] [Abstract][Full Text] [Related]
17. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial. Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J; J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709 [TBL] [Abstract][Full Text] [Related]
18. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Hopwood P; Haviland JS; Sumo G; Mills J; Bliss JM; Yarnold JR; Lancet Oncol; 2010 Mar; 11(3):231-40. PubMed ID: 20138809 [TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Deantonio L; Gambaro G; Beldì D; Masini L; Tunesi S; Magnani C; Krengli M Radiat Oncol; 2010 Nov; 5():112. PubMed ID: 21092288 [TBL] [Abstract][Full Text] [Related]
20. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients. Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F Breast J; 2011; 17(6):586-93. PubMed ID: 21951485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]